Company intelligence / Profile preview

Capri Pharmaceuticals

Ludhiana, Punjab, India

Ownership: Private
Development stage: Other

Overview

Capri Pharmaceuticals markets a wide portfolio of generic pharmaceuticals covering infectious disease, pain, gastroenterology, and more, supplied in the Indian market for over a decade; clinical trial data not applicable as products are approved generics.

Therapeutic areas: ImmunologyMetabolic DisordersInfectious DiseasesGastroenterologyNeurology
Modalities: Small moleculeEnzymeBiologic
Industry: Biotech

Partnerships

Franchisees across India; no major pharma/biotech partnerships found

Beyond the preview

Go deeper on Capri Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capri Pharmaceuticals.

Explore the full profile